Navigation Links
Iowa State chemists track how drug changes, blocks flu virus
Date:2/1/2008

AMES, Iowa An anti-virus drug attacks influenza A by changing the motion and structure of a proton channel necessary for the virus to infect healthy cells, according to a recently published research paper by two Iowa State University chemists.

Mei Hong, Iowa States John D. Corbett Professor in Chemistry, and Sarah Cady, a graduate student in chemistry, are studying the effects of the antiviral drug amantadine on influenza A. Thats the type of flu bug that most commonly makes people sick and the one that has caused the most serious flu epidemics.

Their findings appear in the Feb. 5 edition of the Proceedings of the National Academy of Sciences.

Hong said the findings are particularly important because mutations of the type A virus are resistant to amantadine treatment.

In the last few years, amantadine resistance has skyrocketed among influenza A viruses in Asia and North America, making it imperative to develop alternative antiviral drugs, Hong and Cady wrote in their paper.

To develop those drugs, Hong said researchers first need to understand exactly how amantadine stops the flu virus.

First, some background about how a flu virus infects a healthy cell: A virus begins the process by attaching itself to a healthy cell. The healthy cell surrounds the flu virus and takes it inside the cell through a process called endocytosis. Once in the cell, the virus uses a protein called M2 to open a channel to the healthy cell. Protons from the healthy cell flow through the channel into the virus and raise its acidity. That triggers the release of the virus genetic material into the healthy cell. The virus hijacks the healthy cells resources and uses them to reproduce and spread the virus.

If the M2 proton channel is blocked, the process doesnt work and a virus cant infect a cell and spread.

Hong and Cady studied the proton channel with the help of solid-state nuclear magnetic resonance spe
'/>"/>

Contact: Mei Hong
mhong@iastate.edu
515-294-3521
Iowa State University
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Sharing Miracles Television Program to Feature North Carolina State Womens Basketball Coach Kay Yow
2. Obesity Action Coalition Calls on the State of Mississippi House of Representatives to Withdraw House Bill 282 Discriminating Against Those Affected by Obesity
3. Experimental Vaccine Halts Prostate Cancer in Mice
4. MedWaves, Inc. Announces Receipt of United States Food and Drug Administration 510k Clearance to Market Its Patented Microwave Coagulation/Ablation System
5. CAHI Releases Updated Health Insurance Mandates in the States
6. Los Angeles Daily Journal Names Richardson & Patel Verdict Top in the State of California for 2007
7. SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services
8. Researchers investigate links between prostate, cadmium, zinc
9. Pennsylvania Education Secretary Lauds Action on Measure to Create Statewide School Health Benefits System
10. Urinary dysfunction troubles men who undergo prostate removal
11. Capital BlueCross CEO Says Meaningful Statewide Competition Must Be Key Criteria in Pennsylvanias Review of Proposed Highmark-IBC Merger
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Iowa State chemists track how drug changes, blocks flu virus
Iowa State chemists track how drug changes, blocks flu virus
(Date:1/8/2009)...ire/ -- Susan Knapp Pinnas, a leader of provider,... diversified healthcare,experience, has been name...e,company announced today. , As a member o... be,responsible for advancing AvMed,s overall pro...of strong relationships and service excellence. P...
(Date:1/8/2009)...and Education Act Mandates Label Accuracy, Truth i...GTON, Jan. 8 In respons... dietary supplement regulation, the Natural Produc... Seckman, released this statement: , , Increase...id usage, which the Natural Products Association (...
(Date:1/8/2009)...fficials Expect to Maintain or Increase Spending A... Roads and Bridges, Creation of 21st Century Schoo...ent Facilities , , SEATTLE, Jan. 8 /PRNewswire-...mic stimulus package outlines a significant increa...ion of roads and bridges, 21st-century school proj...
(Date:1/8/2009)...likely to be deadly for women and African-American...enomenon account for only part of the differences ... counterparts, according to results published in t...esults present a stark question for doctors and pa...se upon diagnosis don,t account for all the increa...
Breaking Medicine News(10 mins):Health News:Susan Knapp Pinnas Named AvMed Health Plans' New Senior Vice President of Network 2Health News:Natural Products Association Advocates Strength of Dietary Supplement Law 2Health News:Government at all Levels Will Continue to Spend on Essential Services and Invest in the Future, According to Onvia Study 2Health News:Government at all Levels Will Continue to Spend on Essential Services and Invest in the Future, According to Onvia Study 3Health News:Government at all Levels Will Continue to Spend on Essential Services and Invest in the Future, According to Onvia Study 4Health News:Why bladder cancer is deadlier for some 2Health News:Why bladder cancer is deadlier for some 3Health News:Why bladder cancer is deadlier for some 4
...nown as ReVia, is an approved drug for the treatme...with the drug is it is taken orally, which can red...ifferently in the body. A new study looks at an in...f its use for alcoholics. For the study 315 alcoh...
...a history of an ischemic stroke, which is a stroke... clopidogrel. // However, new research shows this ...stroke. Researchers conducted a study to see if ad...patients would be beneficial as it is in heart dis...
... Taiwan suggests drinking tea may keep your blood ...now discovered // that people who drank between 12...ng tea a day for a year had a 46-percent decreased...id not drink tea regularly. People who consumed mo...
...success reducing pain in patients with multiple sc...abinol, also known as Marinol, has been used to so...rs evaluated the effect of Dronabinol on pain in p...ents with multiple sclerosis and central pain par...
Other Medicine News:
(Date:1/6/2009)...Jan. 6 The Michael J. F...n to four industry research teams for pre-clinical...n,s disease. , , The funding was awarded under ...ive. This program, first launched in 2006, suppor...son,s research. TDI is part of MJFF,s focus on ...
(Date:1/6/2009)... France, January 6 , ... Collaboration Until,December 2011 , - Exp...e Antibody,Discovery in Ophthalmology , - ...f Allergan,Sublicenses to a Third Party , ...nounced a reinforcement,of its existing drug disc...
(Date:1/3/2009)... , , ROSEMONT, Ill., Jan. 2 /PRNewswi... is a growing technology providing an increasing n...tion of back pain according to an article in the J...cademy of Orthopaedic Surgeons ( http://www.jaaos....l years, additional technical developments will al...
(Date:12/27/2008)...MAS, Calif., Dec. 27 According to ...st advised to consume modest doses of,resveratrol...ly provided in 3,to 5 glasses of aged, red wine, ...http://www.newscom.com/cgi-bin/prnh/20080603/LATU0...se resveratrol alone fails to prolong,the life of...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines 7712 1Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines 7712 2Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 1Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 2Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 3Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 4Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model 7710 5NIEHS invests 2421 25 million to find environmental causes of Parkinsons disease 4906 1NIEHS invests 2421 25 million to find environmental causes of Parkinsons disease 4906 2NIEHS invests 2421 25 million to find environmental causes of Parkinsons disease 4906 3Expert urges FDA to take action to reduce BPA exposure 4904 1Expert urges FDA to take action to reduce BPA exposure 4904 2
...ng,poliomyelitis from the remaining infected count... than the long term costs of trying,to control inf...ped,monovalent vaccine is almost three times more ...sting trivalent vaccine. These are,the findings of...issue of The Lancet. , Both Articles look at the s...
...), a,biopharmaceutical company specializing in dev...Lipoprotein (HDL), often called,"good cholesterol,...s of the Phase I/II Clinical Trial of its lead pro...ent of dyslipidemia and,heart disease. , A detaile...,blood chemistry and blood pressure measurements w...
Other Medicine Technology:Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3
The OraQuick ADVANCE Rapid HIV-1/2 Antibody Test is a single-use, qualitative immunoassay to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in oral fluid, fingers
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple
Standard Trephine
Coronet Vacuum Trephine - All metal, ergonomic design and ultra sharp blade with cross hairs.
Medicine Products: